Recombinant EGFR/MMP-2 bi-targeted fusion protein markedly binding to non-small-cell lung carcinoma and exerting potent therapeutic efficacy
Jian Xu(University of California, Los Angeles), Yong‐Su Zhen(Chinese Academy of Medical Sciences & Peking Union Medical College), Yue Du(Shandong University of Technology), Shenghua Zhang(State Ethnic Affairs Commission), Xiaofei Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Ruiqi Wang(University of Connecticut), Liang Li(Shanghai Public Health Clinical Center), Liang Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Xiujun Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Bing‐Yan Zhu(Dalian University of Technology), Chuan-Kun Shan(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 31
Related Papers
HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer
|Gastric Cancer|2014|615
Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis
|Molecular Carcinogenesis|2010|558
Drug resistance to targeted therapeutic strategies in non-small cell lung cancer
|Pharmacology & Therapeutics|2019|245
Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations
|Nature Genetics|2011|198
Nanoparticle Systems for Cancer Vaccine
|Nanomedicine|2019|145